| BCBS Federal Medical & Drug | 5.50.012 Entyvio (vedolizumab) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.50.015 5-HT3 Antagonists | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.50.016 Doxylamine Pyridoxine | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.50.017 Cannabinoids | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.50.022 Amitiza (lubiprostone) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.50.023 Linzess (linaclotide) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.50.028 Barhemsys (amisulpride) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.50.031 Bylvay (odevixibat) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.50.033 Dartisla ODT (glycopyrrolate) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.50.037 Velsipity (etrasimod) | 2026-03-06 |